153 related articles for article (PubMed ID: 10637602)
21. The death effector domain protein PEA-15 prevents nuclear entry of ERK2 by inhibiting required interactions.
Whitehurst AW; Robinson FL; Moore MS; Cobb MH
J Biol Chem; 2004 Mar; 279(13):12840-7. PubMed ID: 14707138
[TBL] [Abstract][Full Text] [Related]
22. Adenovirus-mediated overexpression and stimulation of the human angiotensin II type 2 receptor in porcine cardiac fibroblasts does not modulate proliferation, collagen I mRNA expression and ERK1/ERK2 activity, but inhibits protein tyrosine phosphatases.
Warnecke C; Kaup D; Marienfeld U; Poller W; Yankah C; Gräfe M; Fleck E; Regitz-Zagrosek V
J Mol Med (Berl); 2001 Sep; 79(9):510-21. PubMed ID: 11692164
[TBL] [Abstract][Full Text] [Related]
23. Estrogens do not modify MAP kinase-dependent nuclear signaling during stimulation of early G(1) progression in human breast cancer cells.
Caristi S; Galera JL; Matarese F; Imai M; Caporali S; Cancemi M; Altucci L; Cicatiello L; Teti D; Bresciani F; Weisz A
Cancer Res; 2001 Sep; 61(17):6360-6. PubMed ID: 11522626
[TBL] [Abstract][Full Text] [Related]
24. Mitogen-activated protein kinase activation during IgG-dependent phagocytosis in human neutrophils: inhibition by ceramide.
Suchard SJ; Mansfield PJ; Boxer LA; Shayman JA
J Immunol; 1997 May; 158(10):4961-7. PubMed ID: 9144515
[TBL] [Abstract][Full Text] [Related]
25. Regulation of SMRT corepressor dimerization and composition by MAP kinase phosphorylation.
Varlakhanova N; Hahm JB; Privalsky ML
Mol Cell Endocrinol; 2011 Jan; 332(1-2):180-8. PubMed ID: 20965228
[TBL] [Abstract][Full Text] [Related]
26. Catalytic activation of mitogen-activated protein (MAP) kinase phosphatase-1 by binding to p38 MAP kinase: critical role of the p38 C-terminal domain in its negative regulation.
Hutter D; Chen P; Barnes J; Liu Y
Biochem J; 2000 Nov; 352 Pt 1(Pt 1):155-63. PubMed ID: 11062068
[TBL] [Abstract][Full Text] [Related]
27. The MAP-kinase ERK2 is a specific substrate of the protein tyrosine phosphatase HePTP.
Pettiford SM; Herbst R
Oncogene; 2000 Feb; 19(7):858-69. PubMed ID: 10702794
[TBL] [Abstract][Full Text] [Related]
28. Identification of an activator of the microtubule-associated protein 2 kinases ERK1 and ERK2 in PC12 cells stimulated with nerve growth factor or bradykinin.
Ahn NG; Robbins DJ; Haycock JW; Seger R; Cobb MH; Krebs EG
J Neurochem; 1992 Jul; 59(1):147-56. PubMed ID: 1319464
[TBL] [Abstract][Full Text] [Related]
29. KCl potentiates forskolin-induced PC12 cell neurite outgrowth via protein kinase A and extracellular signal-regulated kinase signaling pathways.
Hansen Tv; Rehfeld JF; Nielsen FC
Neurosci Lett; 2003 Aug; 347(1):57-61. PubMed ID: 12865141
[TBL] [Abstract][Full Text] [Related]
30. Examining the mechanism of Erk nuclear translocation using green fluorescent protein.
Horgan AM; Stork PJ
Exp Cell Res; 2003 May; 285(2):208-20. PubMed ID: 12706116
[TBL] [Abstract][Full Text] [Related]
31. Characterization of mitogen-activated protein kinase (MAPK) dimers.
Wilsbacher JL; Juang YC; Khokhlatchev AV; Gallagher E; Binns D; Goldsmith EJ; Cobb MH
Biochemistry; 2006 Nov; 45(44):13175-82. PubMed ID: 17073439
[TBL] [Abstract][Full Text] [Related]
32. Reconstitution of the nuclear transport of the MAP kinase ERK2.
Jivan A; Ranganathan A; Cobb MH
Methods Mol Biol; 2010; 661():273-85. PubMed ID: 20811989
[TBL] [Abstract][Full Text] [Related]
33. Prolonged extracellular signal-regulated kinase 1/2 activation during fibroblast growth factor 1- or heregulin beta1-induced antiestrogen-resistant growth of breast cancer cells is resistant to mitogen-activated protein/extracellular regulated kinase kinase inhibitors.
Thottassery JV; Sun Y; Westbrook L; Rentz SS; Manuvakhova M; Qu Z; Samuel S; Upshaw R; Cunningham A; Kern FG
Cancer Res; 2004 Jul; 64(13):4637-47. PubMed ID: 15231676
[TBL] [Abstract][Full Text] [Related]
34. Lysophosphatidic acid stimulates CREB through mitogen- and stress-activated protein kinase-1.
Lee CW; Nam JS; Park YK; Choi HK; Lee JH; Kim NH; Cho J; Song DK; Suh HW; Lee J; Kim YH; Huh SO
Biochem Biophys Res Commun; 2003 Jun; 305(3):455-61. PubMed ID: 12763014
[TBL] [Abstract][Full Text] [Related]
35. Sustained activation of the extracellular signal-regulated kinase pathway protects cells from photofrin-mediated photodynamic therapy.
Tong Z; Singh G; Rainbow AJ
Cancer Res; 2002 Oct; 62(19):5528-35. PubMed ID: 12359764
[TBL] [Abstract][Full Text] [Related]
36. Involvement of ERK in BMP-2 induced osteoblastic differentiation of mesenchymal progenitor cell line C3H10T1/2.
Lou J; Tu Y; Li S; Manske PR
Biochem Biophys Res Commun; 2000 Feb; 268(3):757-62. PubMed ID: 10679278
[TBL] [Abstract][Full Text] [Related]
37. The N-terminal domain of ERK1 accounts for the functional differences with ERK2.
Marchi M; D'Antoni A; Formentini I; Parra R; Brambilla R; Ratto GM; Costa M
PLoS One; 2008; 3(12):e3873. PubMed ID: 19052640
[TBL] [Abstract][Full Text] [Related]
38. UCN-01-induced cell cycle arrest requires the transcriptional induction of p21(waf1/cip1) by activation of mitogen-activated protein/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase pathway.
Facchinetti MM; De Siervi A; Toskos D; Senderowicz AM
Cancer Res; 2004 May; 64(10):3629-37. PubMed ID: 15150122
[TBL] [Abstract][Full Text] [Related]
39. Extremely low-dose ionizing radiation causes activation of mitogen-activated protein kinase pathway and enhances proliferation of normal human diploid cells.
Suzuki K; Kodama S; Watanabe M
Cancer Res; 2001 Jul; 61(14):5396-401. PubMed ID: 11454682
[TBL] [Abstract][Full Text] [Related]
40. Localization and trafficking of fluorescently tagged ERK1 and ERK2.
Marchi M; Parra R; Costa M; Ratto GM
Methods Mol Biol; 2010; 661():287-301. PubMed ID: 20811990
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
